PT - JOURNAL ARTICLE AU - Lépine, Aurélia AU - Szawlowski, Sandie AU - Nitcheu, Emile AU - Cust, Henry AU - Tamgno, Eric Defo AU - Noo, Julienne AU - Procureur, Fanny AU - Mfochive, Illiasou AU - Billong, Serge AU - Tamoufe, Ubald TI - Protecting women from economic shocks to prevent HIV in Africa: Evidence from the POWER randomised controlled trial in Cameroon AID - 10.1101/2024.02.02.24302170 DP - 2024 Jan 01 TA - medRxiv PG - 2024.02.02.24302170 4099 - http://medrxiv.org/content/early/2024/02/03/2024.02.02.24302170.short 4100 - http://medrxiv.org/content/early/2024/02/03/2024.02.02.24302170.full AB - Background Women in Sub-Saharan Africa are disproportionately affected by the HIV epidemic. Young women are twice as likely to be living with HIV than men of the same age and account for 64% of new HIV infections among young people. Many studies suggest that financial needs, alongside biological susceptibility, are the main causes of the gender disparity in HIV acquisition. While the literature shows a limited understanding of the link between poverty and HIV, there is some new robust evidence demonstrating that women adopt risky sexual behaviours as a way to cope with economic shocks.Methods We recruited 1,506 adolescent girls and women engaging in transactional or in commercial sex in Yaounde, Cameroon, using snowball sampling. Half of the study participants were randomly allocated to receive a free health insurance product covering themselves and their economic dependents over 12 months. We collected data on socio-economics, health and sexual behaviours and sexually transmitted infection and HIV biomarkers at baseline, 6-month post randomisation (midline) and 12-month post randomisation (endline).Results We found that study participants engaging in transactional sex allocated to the treatment group were less likely to be infected with HIV (OR=0.109, p-value<0.05). We showed that the intervention allowed women to leave transactional sex. In addition, we found that for the participants remaining in transactional sex, the intervention increased condom use and reduced sex acts, these results were however only statistically significant at 10% given our sample size. There was no evidence of a change in risky sexual behaviours or in a reduction of HIV incidence among female sex workers.Conclusion The study provides the first evidence of the effectiveness of a formal shock-coping strategy to prevent HIV among women in Africa. We showed that the intervention effectiveness operates through the reduction in health shocks since the increase in healthcare use following the intervention was low. We estimated that in our trial, the cost for each HIV infection averted is £4,667 among the cohort of women engaging in transactional sex. Policymakers should consider formal shock-coping strategies to prevent HIV among women in Africa.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN22516548Funding StatementThe study is funded by the UKRI Future Leaders Fellowship awarded to Dr LepineAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UCL ethics committee and national ethics committee in CameroonI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.